Micro- and Nanorobots in Cancer Therapy: From Active Drug Delivery to Clinical Translation

Abstract Micro- and nanorobotic systems represent an emerging approach to overcoming some of the limitations of conventional anticancer drug delivery. Unlike passive nanocarriers, these systems can exploit externally controlled or autonomous propulsion mechanisms to navigate through biological environments, transport therapeutic agents, and potentially improve their distribution within tumour tissues. Various platforms have been investigated, including magnetically actuated microrobots, chemically propelled Janus particles, acoustically responsive systems, and biohybrid devices incorporating bacteria, sperm cells, or microalgae. Recent preclinical investigations have demonstrated the feasibility of delivering therapeutic agents to poorly accessible anatomical compartments, including hypoxic tumour regions and pulmonary metastases. However, substantial challenges remain regarding physiological navigation, drug-loading capacity, pharmacokinetics, biodistribution, biocompatibility, pharmaceutical stability, manufacturing reproducibility, and regulatory evaluation. Importantly, the demonstration of successful propulsion or increased tumour accumulation does not necessarily establish therapeutic efficacy. This review critically examines the technological principles and experimental applications of micro- and nanorobots in oncology, with particular emphasis on pharmaceutical performance and the challenges associated with clinical translation.

Authors

Publication Details

Published
2026-11-12
DOI
https://doi.org/10.66696/b8010742-9690-44b7-9876-b9395d19c853
Primary Topic
Micro and Nano Robotics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Micro- and Nanorobots in Cancer Therapy: From Active Drug Delivery to Clinical Translation

ASTIER Alain
Micro and Nano Robotics
article

Micro- and Nanorobots in Cancer Therapy: From Active Drug Delivery to Clinical Translation

ASTIER Alain
article en

Abstract

Abstract Micro- and nanorobotic systems represent an emerging approach to overcoming some of the limitations of conventional anticancer drug delivery. Unlike passive nanocarriers, these systems can exploit externally controlled or autonomous propulsion mechanisms to navigate through biological environments, transport therapeutic agents, and potentially improve their distribution within tumour tissues. Various platforms have been investigated, including magnetically actuated microrobots, chemically propelled Janus particles, acoustically responsive systems, and biohybrid devices incorporating bacteria, sperm cells, or microalgae. Recent preclinical investigations have demonstrated the feasibility of delivering therapeutic agents to poorly accessible anatomical compartments, including hypoxic tumour regions and pulmonary metastases. However, substantial challenges remain regarding physiological navigation, drug-loading capacity, pharmacokinetics, biodistribution, biocompatibility, pharmaceutical stability, manufacturing reproducibility, and regulatory evaluation. Importantly, the demonstration of successful propulsion or increased tumour accumulation does not necessarily establish therapeutic efficacy. This review critically examines the technological principles and experimental applications of micro- and nanorobots in oncology, with particular emphasis on pharmaceutical performance and the challenges associated with clinical translation.

Vol. 1(1)
Good health and well-being
Micro and Nano Robotics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon